Cancer incidence and the influence of immunosuppressive agents in Korean patients with systemic lupus erythematosus: a retrospective cohort study
Our study shows that Korean SLE patients using immunosuppressive agents are not significantly more likely to develop cancer. Further research with extended observation is warranted to corroborate these findings.
Authors
- Soo‐Kyung Cho (ORCID: https://orcid.org/0000-0003-4493-8837)
- Yena Jeon (ORCID: https://orcid.org/0000-0002-4857-8616)
- Yoon‐Kyoung Sung (ORCID: https://orcid.org/0000-0001-6691-8939)
- Jung-Yong Han (ORCID: https://orcid.org/0000-0002-0196-9038)
- Seung‐Hun You (ORCID: https://orcid.org/0000-0002-2430-6907)
- Sun-Young Jung (ORCID: https://orcid.org/0000-0001-5002-9846)
- Eun Jin Jang
Institutions
- Gyeongguk National University (KR)
- Kyungpook National University (KR)
- Hanyang University Seoul Hospital (KR)
- Hanyang University (KR)
- Chung-Ang University (KR)
Publication Details
- Journal
- Arthritis Research & Therapy
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1186/s13075-025-03482-2
- Citations
- 2
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 3.34
Funders
- Korea Health Industry Development Institute